Related Experiment Video
Updated: Nov 4, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
A systematic analysis of signaling reactivation and drug resistance
Boris N Kholodenko1, Nora Rauch2, Walter Kolch3
1Systems Biology Ireland, School of Medicine and Medical Science, University College Dublin, Dublin, Ireland; Conway Institute of Biomolecular & Biomedical Research, University College Dublin, Dublin, Ireland; Department of Pharmacology, Yale University School of Medicine, New Haven, CT, USA.
Abstract:
Increasing evidence suggests that the reactivation of initially inhibited signaling pathways causes drug resistance. Here, we analyze how network topologies affect signaling responses to drug treatment. Network-dependent drug resistance is commonly attributed to negative and positive feedback loops. However, feedback loops by themselves cannot completely reactivate steady-state signaling. Newly synthesized negative feedback regulators can induce a transient overshoot but cannot fully restore output signaling. Complete signaling reactivation can only occur when at least two routes, an activating and inhibitory, connect an inhibited upstream protein to a downstream output. Irrespective of the network topology, drug-induced overexpression or increase in target dimerization can restore or even paradoxically increase downstream pathway activity. Kinase dimerization cooperates with inhibitor-mediated alleviation of negative feedback. Our findings inform drug development by considering network context and optimizing the design drug combinations. As an example, we predict and experimentally confirm specific combinations of RAF inhibitors that block mutant NRAS signaling.
Insights
Drug resistance stems from reactivated signaling pathways. Complete reactivation requires dual pathways, not just feedback loops, informing new drug combination strategies.
Area of Science:
- Systems Biology
- Pharmacology
- Molecular Biology
Background:
- Drug resistance is a significant challenge in cancer therapy.
- Reactivation of signaling pathways is a known mechanism of drug resistance.
- Network topology's role in this reactivation is not fully understood.
Purpose of the Study:
- To investigate how different biological network structures influence signaling pathway reactivation after drug treatment.
- To elucidate the mechanisms underlying network-dependent drug resistance.
- To identify strategies for optimizing drug combinations to overcome resistance.
Main Methods:
- Analysis of signaling network topologies under simulated drug treatment.
- Mathematical modeling of pathway dynamics.
- Experimental validation of predicted resistance mechanisms and drug combinations.
Main Results:
- Feedback loops alone are insufficient for complete signaling reactivation.
- Complete reactivation requires at least two distinct pathways (activating and inhibitory) from an upstream protein to a downstream output.
- Drug-induced target dimerization and alleviation of negative feedback can paradoxically enhance pathway activity.
Conclusions:
- Network context is crucial for understanding and predicting drug resistance.
- Dual-pathway reactivation is a key mechanism for complete signaling restoration.
- Targeted drug combinations, considering network topology and dimerization, can effectively block resistance, as demonstrated with RAF inhibitors against mutant NRAS signaling.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
09:58Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
Related Concept Videos
Treatment Resistant Cancers
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Signal Transduction: Overview
Typically, signal transduction involves three...
Amplifying Signals via Enzymatic Cascade
mTOR Signaling and Cancer Progression
The mTOR pathway or the...